Supplementary table 2 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
Published in 2023 by
Richard P. Tobin 
,
Dasha T. Cogswell,
Victoria M. Cates,
Dana M. Davis,
Jessica S. W. Borgers,
Robert J. Van Gulick,
Elizabeth Katsnelson,
Kasey L. Couts,
Kimberly R. Jordan,
Dexiang Gao ,
Eduardo Davila,
Theresa M. Medina,
Karl D. Lewis,
Rene Gonzalez,
Ross W. McFarland
and other authors.
,
Dasha T. Cogswell,
Victoria M. Cates,
Dana M. Davis,
Jessica S. W. Borgers,
Robert J. Van Gulick,
Elizabeth Katsnelson,
Kasey L. Couts,
Kimberly R. Jordan,
Dexiang Gao ,
Eduardo Davila,
Theresa M. Medina,
Karl D. Lewis,
Rene Gonzalez,
Ross W. McFarland
and other authors.
